Co-Authors
This is a "connection" page, showing publications co-authored by BENJAMIN SHNEIDER and DANIEL LEUNG.
Connection Strength
1.386
-
Educating pediatric gastroenterology fellows: Milestones, EPAs, & their application within a new educational curriculum. J Pediatr Gastroenterol Nutr. 2024 Jun; 78(6):1213-1216.
Score: 0.238
-
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease. Hepatology. 2023 02 01; 77(2):530-545.
Score: 0.216
-
Operational Definitions for Chronic Liver Disease Manifestations and Recurring Clinical Events in Biliary Atresia. J Pediatr Gastroenterol Nutr. 2021 04 01; 72(4):584-591.
Score: 0.193
-
Nonfasted Liver Stiffness Correlates with Liver Disease Parameters and Portal Hypertension in Pediatric Cholestatic Liver Disease. Hepatol Commun. 2020 Nov; 4(11):1694-1707.
Score: 0.185
-
Placebo-Controlled Randomized Trial of an Intestinal Bile Salt Transport Inhibitor for Pruritus in Alagille Syndrome. Hepatol Commun. 2018 Oct; 2(10):1184-1198.
Score: 0.162
-
Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: Summary of the Baveno VI Pediatric Satellite Symposium. Hepatology. 2016 Apr; 63(4):1368-80.
Score: 0.132
-
Prospective Analysis of Liver Stiffness Measurement by Vibration Controlled Transient Elastography as a Predictor of Outcomes in Biliary Atresia. Gastroenterology. 2024 Oct 18.
Score: 0.062
-
Impact of long-term administration of maralixibat on children with cholestasis secondary to Alagille syndrome. Hepatol Commun. 2022 08; 6(8):1922-1933.
Score: 0.052
-
Risk of variceal hemorrhage and pretransplant mortality in children with biliary atresia. Hepatology. 2022 09; 76(3):712-726.
Score: 0.052
-
Biomarkers for liver disease in urea cycle disorders. Mol Genet Metab. 2021 06; 133(2):148-156.
Score: 0.048
-
Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency. JCI Insight. 2020 02 27; 5(4).
Score: 0.045